These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7002787)

  • 1. Characterization of Shigella dysenteriae 1 (Shiga) toxin purified by anti-Shiga toxin affinity chromatography.
    O'Brien AD; LaVeck GD; Griffin DE; Thompson MR
    Infect Immun; 1980 Oct; 30(1):170-9. PubMed ID: 7002787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and biological characterization of shiga toxin from Shigella dysenteriae 1.
    Brown JE; Griffin DE; Rothman SW; Doctor BP
    Infect Immun; 1982 Jun; 36(3):996-1005. PubMed ID: 7047403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal toxicity of Shigella dysenteriae cytotoxin: evidence that the neurotoxic, enterotoxic, and cytotoxic activities are due to one toxin.
    Eiklid K; Olsnes S
    J Immunol; 1983 Jan; 130(1):380-4. PubMed ID: 6336624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and some properties of Shiga-like toxin from Escherichia coli O157:H7 that is immunologically identical to Shiga toxin.
    Noda M; Yutsudo T; Nakabayashi N; Hirayama T; Takeda Y
    Microb Pathog; 1987 May; 2(5):339-49. PubMed ID: 3148810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of purified Shiga toxin from Shigella dysenteriae 1.
    Yutsudo T; Honda T; Miwatani T; Takeda Y
    Microbiol Immunol; 1986; 30(11):1115-27. PubMed ID: 3100915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of an Escherichia coli Shiga-like toxin II variant.
    MacLeod DL; Gyles CL
    Infect Immun; 1990 May; 58(5):1232-9. PubMed ID: 2182539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of a lethal toxin produced by Shigella dysenteriae.
    Okamoto K; Takeda Y; Miwatani T
    Toxicon; 1982; 20(2):451-6. PubMed ID: 7043787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coli.
    O'Brien AD; LaVeck GD
    Infect Immun; 1983 May; 40(2):675-83. PubMed ID: 6341244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies.
    Donohue-Rolfe A; Keusch GT; Edson C; Thorley-Lawson D; Jacewicz M
    J Exp Med; 1984 Dec; 160(6):1767-81. PubMed ID: 6392471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic peptides of Shiga toxin B subunit induce antibodies which neutralize its biological activity.
    Harari I; Donohue-Rolfe A; Keusch G; Arnon R
    Infect Immun; 1988 Jun; 56(6):1618-24. PubMed ID: 3286503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production, characterization and immunodiagnostic application of a monoclonal antibody to Shiga toxin.
    Qadri F; Mohi MG; Azim T; Faruque SM; Kabir AK; Albert MJ
    J Diarrhoeal Dis Res; 1996 Jun; 14(2):95-100. PubMed ID: 8870402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of Shiga toxin and other cytotoxins by serogroups of Shigella.
    Bartlett AV; Prado D; Cleary TG; Pickering LK
    J Infect Dis; 1986 Dec; 154(6):996-1002. PubMed ID: 3537154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of Shiga toxin by alpha-D-galactose-(1----4)-beta-D-galactose-(1----4)-beta-D-glucose-(1- ---) receptor ligand-based chromatography.
    Ryd M; Alfredsson H; Blomberg L; Andersson A; Lindberg AA
    FEBS Lett; 1989 Dec; 258(2):320-2. PubMed ID: 2689221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies.
    Donohue-Rolfe A; Acheson DW; Kane AV; Keusch GT
    Infect Immun; 1989 Dec; 57(12):3888-93. PubMed ID: 2807552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A monoclonal antibody to Shigella dysenteriae serotype 13 cross-reacting with Shiga toxin.
    Qadri F; Azim T; Hossain A; Islam D; Mondol G; Faruque SM; Albert MJ
    FEMS Microbiol Lett; 1993 Mar; 107(2-3):343-7. PubMed ID: 8472916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of Clostridium sordellii hemorrhagic toxin and cross-reactivity with Clostridium difficile toxin A (enterotoxin).
    Martinez RD; Wilkins TD
    Infect Immun; 1988 May; 56(5):1215-21. PubMed ID: 3128481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicochemical characterization of A and B subunits of Shiga toxin and reconstitution of holotoxin from isolated subunits.
    Yutsudo T; Honda T; Miwatani T; Takeda Y
    Microbiol Immunol; 1987; 31(3):189-97. PubMed ID: 3302622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digalactosyl-containing glycolipids as cell surface receptors for shiga toxin of Shigella dysenteriae 1 and related cytotoxins of Escherichia coli.
    Brown JE; Echeverria P; Lindberg AA
    Rev Infect Dis; 1991; 13 Suppl 4():S298-303. PubMed ID: 2047653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathogenesis of Shigella diarrhea. V. Relationship of shiga enterotoxin, neurotoxin, and cytotoxin.
    Keusch GT; Jacewicz M
    J Infect Dis; 1975 May; 131 Suppl():S33-9. PubMed ID: 236346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on shiga-like toxin produced by enterohemorrhagic Escherichia coli: purification and characterization of the toxin and development of methods for identifying the toxin.
    Kongmuang U
    Med J Osaka Univ; 1989 Mar; 38(1-4):39-49. PubMed ID: 2485395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.